“Ansell Microflex Diamond Grip Gloves Recall: Barrier Integrity Issue.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/64449-ansell-microflex-diamond-grip-gloves-recall-barrier-integrity-issue. Based on FDA recall #Z-0051-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0051-2021%22&limit=1).
Ansell Healthcare Products LLC recalled MICROFLEX Diamond Grip Examination Gloves, MF-300 due to a barrier integrity verification failure, the FDA said on Aug. 19, 2020. Owners should contact the company for a refund.
The examination gloves were shipped without verification of barrier integrity, which could allow contamination between patient and examiner. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Ansell Healthcare Products LLC has two other recalls on record since Feb. 19, 2022. On Aug. 3, 2023, the company recalled PI Green Surgical Gloves due to unsealed sterile pouches. Other recent recalls of similar products include Performance Pro Blue Nitrile Gloves Recall (Aug. 14, 2026) and Halyard Purezero Ultraviolet Nitrile Exam Gloves Recall (April 13, 2026).
How to tell if you have this one
Check for the lot number 2003LG and batch number 20035314LG on the packaging. These gloves are used for medical examinations and are disposable.
Brand
Ansell Healthcare
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number 2003LG and batch number 20035314LG on the packaging to identify affected items.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 28 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “U.S. Nationwide distribution including in the states of IL, OK, WI, PA, TX, OH, MI, IN, VA, AR, KS, MO, NV, OR, FL, QC, NJ, NE, KY, AL, TN, LA, NY, SC, MS, MD, CA, GA, SD.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arkansas, California, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maryland, Michigan, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Virginia, Wisconsin.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0051-2021 (August 19, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0051-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.